Perioperative β-blockade:: How best to translate evidence into practice

[11] Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (23) : 1713 - 1720

[12] A meta-analysis of perioperative beta blockade: What is the actual risk reduction? [J]. SURGERY, 2005, 138 (02) : 171 - 179

[13] Missed opportunities to treat atherosclerosis in patients undergoing peripheral vascular interventions -: Insights from the University of Michigan peripheral vascular disease quality improvement initiative (PVD-QI2) [J]. CIRCULATION, 2002, 106 (15) : 1909 - 1912

[14] Nass CM, 2001, VASC MED, V6, P35, DOI 10.1191/135886301671753754

[15] Should major vascular surgery be delayed because of preoperative cardiac testing in intermediate-risk patients receiving beta-blocker therapy with tight heart rate control? [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 48 (05) : 964 - 969

[16] Postoperative management strategies may obviate the need for most preoperative cardiac testing [J]. ANESTHESIOLOGY, 1996, 84 (05) : 1266 - 1267

[17] Pro: Beta-blockers are indicated for patients at risk for cardiac complications undergoing noncardiac surgery [J]. ANESTHESIA AND ANALGESIA, 2007, 104 (01) : 8 - 10

[18] Safe but sound - Patient safety meets evidence-based medicine [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (04): : 508 - 513

[19] AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update - Endorsed by the National Heart, Lung, and Blood Institute [J]. CIRCULATION, 2006, 113 (19) : 2363 - 2372

[20] Pharmacologic myocardial protection in patients undergoing noncardiac surgery:: A quantitative systematic review [J]. ANESTHESIA AND ANALGESIA, 2003, 97 (03) : 623 - 633

[11] Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (23) : 1713 - 1720

[12] A meta-analysis of perioperative beta blockade: What is the actual risk reduction? [J]. SURGERY, 2005, 138 (02) : 171 - 179

[13] Missed opportunities to treat atherosclerosis in patients undergoing peripheral vascular interventions -: Insights from the University of Michigan peripheral vascular disease quality improvement initiative (PVD-QI2) [J]. CIRCULATION, 2002, 106 (15) : 1909 - 1912

[14] Nass CM, 2001, VASC MED, V6, P35, DOI 10.1191/135886301671753754

[15] Should major vascular surgery be delayed because of preoperative cardiac testing in intermediate-risk patients receiving beta-blocker therapy with tight heart rate control? [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 48 (05) : 964 - 969

[16] Postoperative management strategies may obviate the need for most preoperative cardiac testing [J]. ANESTHESIOLOGY, 1996, 84 (05) : 1266 - 1267

[17] Pro: Beta-blockers are indicated for patients at risk for cardiac complications undergoing noncardiac surgery [J]. ANESTHESIA AND ANALGESIA, 2007, 104 (01) : 8 - 10

[18] Safe but sound - Patient safety meets evidence-based medicine [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (04): : 508 - 513

[19] AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update - Endorsed by the National Heart, Lung, and Blood Institute [J]. CIRCULATION, 2006, 113 (19) : 2363 - 2372

[20] Pharmacologic myocardial protection in patients undergoing noncardiac surgery:: A quantitative systematic review [J]. ANESTHESIA AND ANALGESIA, 2003, 97 (03) : 623 - 633